ARYA Sciences Acquisition Corp IV

ARYA Sciences Acquisition Corp IV, trading under the ticker ARYD, is a blank check company sponsored by ARYA Sciences Holdings IV, an affiliate of Perceptive Advisors, a healthcare-focused investment firm with a long track record in life sciences. The company completed its initial public offering in 2021 and targets opportunities in the life sciences and biotechnology sector. ARYD filed a Form 10-Q with the SEC on May 13, 2022, reflecting its continued search for a qualifying business combination target as a development-stage entity with no operations of its own. ARYA Sciences has launched multiple SPAC vehicles under the same brand, underscoring its repeated-sponsor strategy in healthcare dealmaking. Sign up for SpacDesk to access the full filing history, deal timeline, and sponsor analytics for ARYD and hundreds of other SPACs.